The impact of USP11 on EGFR signaling was validated using USP11-KO cells, which demonstrated reduced EGFR stability and in vivo tumorigenic effect, and diminished responses to EGF stimulation in migration, proliferation, and 3D tumor spheroid assays. This evidence concerns the gene USP11 and neoplasm.